These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Cardiac transplantation in mice. IV. Relationship between antithymocyte-globulin (ATG) dose, allograft survival and anti-ATG immunity. Judd KP; Bryant CJ; Ruckman RJ; Trentin JJ Rev Eur Etud Clin Biol; 1971 Dec; 16(10):1002-6. PubMed ID: 4400851 [No Abstract] [Full Text] [Related]
30. Prolongation of pancreatic islet cell allograft survival by graft pretreatment with antilymphoblast globulin (ALG). Toledo-Pereyra LH; Gordon DA; MacKenzie GH Am Surg; 1982 Jun; 48(6):282-6. PubMed ID: 6805380 [TBL] [Abstract][Full Text] [Related]
31. Intrathymic injection of donor splenocytes plus systemic antilymphocyte serum or antilymphocyte serum alone prolongs cardiac allograft survival and inhibits graft arteriosclerosis in the Lewis-to-F344 chronic rejection model. Shin YT; Adams DH; Wyner LR; Akalin E; Sayegh MH; Karnovsky MJ Transplant Proc; 1995 Jun; 27(3):2112-4. PubMed ID: 7792902 [No Abstract] [Full Text] [Related]
32. Prolonged allograft survival of strong pretransplant immune responders treated with ATG. Kerman RH; Floyd M; Van Buren CT; Kahan BD Transplant Proc; 1981 Mar; 13(1 Pt 1):332-5. PubMed ID: 6455793 [No Abstract] [Full Text] [Related]
33. Impact of antipassenger lymphocyte globulin on functional graft survival of discordant xenoislet grafts from a large animal donor. Troppmann C; Papalois BE; Gruessner AC; Moon C; Matas AJ; Nakhleh RE; Gruessner RW Transplant Proc; 1996 Apr; 28(2):842-4. PubMed ID: 8623429 [No Abstract] [Full Text] [Related]
34. Effect of prior blood transfusions on marrow grafts: abrogation of sensitization by procarbazine and antithymocyte serum. Storb R; Floersheim GL; Weiden PL; Graham TC; Kolb HJ; Lerner KG; Schroeder ML; Thomas ED J Immunol; 1974 Apr; 112(4):1508-16. PubMed ID: 4592604 [No Abstract] [Full Text] [Related]
35. Sequential use of antithymocyte globulin and cyclosporine augments skin allograft survival. Thomas J; Whitley T; Carver M; Thomas F Transplant Proc; 1984 Dec; 16(6):1522-4. PubMed ID: 6390858 [No Abstract] [Full Text] [Related]
36. Nursing implications of antithymocyte globulin therapy in organ transplantation. Richard AB; Robbins KC; Rovelli MA ANNA J; 1984 Aug; 11(5):20-4. PubMed ID: 6397146 [No Abstract] [Full Text] [Related]
37. Immunologic monitoring of antithymocyte globulin treatment for acute allograft rejection. Delmonico FL; Nelson PW; Colvin RB; Cosimi AB Transplant Proc; 1984 Dec; 16(6):1492-3. PubMed ID: 6390852 [No Abstract] [Full Text] [Related]
38. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome. Koga A; Moreso FJ; Seron D; Gil-Vernet S; Cruzado JM; Castelao AM; Grinyó JM Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318 [TBL] [Abstract][Full Text] [Related]
39. Immunologic monitoring of rabbit antithymocyte globulin-treated transplant recipients: a comparison of serial E-RFC and immunomagnetic quantitation of CD2+ cells. Brinchmann JE; Vartdal F; Forset KL; Thorsby E Transplant Proc; 1988 Jun; 20(3):390-1. PubMed ID: 3289168 [No Abstract] [Full Text] [Related]